Fact CheckerSign in

NCT05874466Recruiting

SenseToKnow Autism Screening Device Validation Study

SenseToKnow STAR Study: A Study of Technologies for Assessing Children's Development

Source: ClinicalTrials.gov · Last updated 6 Mar 2026

Brief summary (registry, in English)

This is a pivotal, prospective, double-blind, study to evaluate the sensitivity and specificity of the SenseToKnow device for the detection of autism spectrum disorder in children 16-36 months of age.

Status (registry)
Recruiting
Study type
Observational
Enrollment
350 (estimated)
First submitted
12 May 2023
Start date
7 Jul 2023
Primary completion date
Dec 2027
Lead sponsor
Duke University
Diseases
Autism
NCT number
NCT05874466

What you commit to

  • Study type: Observational
  • Planned participants: 350
  • From 7 Jul 2023 to the primary completion date, Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Receiving therapies that affect vision

Other illness

  • Severe motor impairment that precludes study measure completion
  • Known genetic disorders
  • Severe hearing or visual impairment as determined on physical examination according to parent report
  • Acute illnesses likely to prevent successful or valid data collection
  • Uncontrolled epilepsy or seizure disorder
  • History or presence of a clinically significant medical disease, or a mental state that could confound the study or be detrimental to the subject as determined by the investigator
  • Acute exacerbations of chronic illnesses likely to prevent successful or valid data collection

Other

  • Parent/legal guardian and/or investigator believes that the child will be unable/unwilling to sit in the parent's lap to watch the app videos
  • Parent/legal guardian indicates that they or their child is unwilling or unable to complete the app administration, surveys, or diagnostic assessment
  • Participants who are otherwise judged as unable to comply with the protocol by the investigator
  • Any other factor that the investigator feels would make the study measures invalid

Who the study is looking for

  • Duke Health pediatric patient at enrollment
  • 16-\<37 months of age at enrollment
  • Parent/legal guardian speaks English or Spanish
  • Parent/legal guardian understands and voluntarily provides informed consent

Age in the registry: 16 months to 36 months · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Duke University
Coordinator of this site? Confirm its status
DurhamUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.